Accotest(SH:688200)2020-10-22 16:00Financial Performance - Net profit attributable to shareholders was CNY 136,746,066.18, representing a growth of 68.05% year-on-year[20]. - Operating revenue for the first nine months was CNY 292,632,885.33, up 45.47% from the same period last year[20]. - Basic earnings per share rose to CNY 2.37, a 30.22% increase compared to the previous year[22]. - The diluted earnings per share also stood at CNY 2.37, reflecting consistent performance[22]. - Net profit for Q3 2020 reached CNY 47,342,720.70, representing a 9.0% increase from CNY 43,387,048.26 in Q3 2019[54]. - Total profit amounted to CNY 35,339,025.14, compared to CNY 21,304,185.86 in the previous year, reflecting a growth of approximately 66%[60]. - Net profit reached CNY 34,260,212.02, up from CNY 19,940,172.18 year-over-year, indicating a growth of about 72%[60]. Revenue and Costs - Total operating revenue for Q3 2020 was CNY 108,579,406.47, an increase of 9.8% compared to CNY 98,921,261.95 in Q3 2019[51]. - Total operating costs for Q3 2020 were CNY 59,943,328.13, up 32.7% from CNY 45,203,509.50 in Q3 2019[51]. - Total operating revenue for the first three quarters of 2020 was CNY 292,632,885.33, compared to CNY 201,166,865.67 in the same period of 2019, marking a 45.5% increase[51]. - Total operating costs for the first three quarters of 2020 were CNY 151,201,507.41, an increase of 45.3% from CNY 104,029,466.52 in the first three quarters of 2019[51]. Cash Flow - Net cash flow from operating activities increased by 833.54% to CNY 94,235,792.44 year-to-date[20]. - Cash flow from financing activities reached CNY 1,472,058,254.82, a dramatic increase of 1,572.69% from CNY 88,005,700.00 last year[34]. - Cash inflow from financing activities amounted to CNY 1,528,613,803.64, up from CNY 110,705,700.00 in 2019, reflecting an increase of about 1,280.5%[75]. - Cash flow from investing activities showed a net outflow of CNY 1,112,660,676.19, compared to a smaller outflow of CNY 5,544,416.00 in the previous year[68]. - The net increase in cash and cash equivalents for the period was CNY 448,352,755.29, compared to CNY 88,364,445.56 in the same period last year, showing an increase of approximately 407.5%[75]. Assets and Liabilities - Total assets reached CNY 2,151,794,154.86, an increase of 335.95% compared to the end of the previous year[20]. - Total liabilities reached approximately $93.01 million, up from $65.57 million, representing an increase of about 41.9%[46]. - Total current liabilities amounted to CNY 65,433,236.84[78]. - Total equity attributable to shareholders reached ¥428,011,297.27, with retained earnings of ¥193,976,572.55[82]. - The company’s total non-current assets rose to approximately $219.36 million from $75.25 million, indicating a growth of approximately 191.5%[46]. Shareholder Information - The total number of shareholders at the end of the reporting period was 6,922[28]. - The largest shareholder, Tianjin Xinhua Investment Holding Co., held 29.79% of shares[28]. Research and Development - R&D expenditure accounted for 13.16% of operating revenue, an increase of 1.42 percentage points[22]. - The company has significantly increased its investment in R&D and new product development, contributing to revenue growth[34]. - Research and development expenses for Q3 2020 were CNY 17,466,501.87, a significant increase of 79.5% compared to CNY 9,749,951.00 in Q3 2019[51]. Other Financial Metrics - The company reported government subsidies of CNY 24,388.98 for the current period[24]. - The company reported a significant increase in inventory, which rose to approximately $50.47 million from $40.95 million, reflecting a growth of about 23.1%[46]. - The company reported a significant increase in other income, totaling CNY 267,971.87, compared to CNY 34,562.03 in the same period last year[60].